"Hey My Beautiful Fans!"
The business model of influencers is in the doldrums because of the many scams and scandals they are involved in. Before the press revealed their misbehaviours, I suggested to the CEO of a "stable of influencers", a way out.
The idea was no longer to promote 2 euro charms (dropshipping) or dangerous cosmetic products through their influencers, but to appeal for donations... with the ultimate aim of investing in biopharmaceutical startups that want to save lives.
The model was that of Social Venture Capital, i.e. a fund managed by a non-profit association which, instead of giving money to scientific research, invests in the capital of health tech startups (biotech, pharma and med tech start-ups).
In this model, the influencers call out their fans on their social networks (Insta, X, TikTok, etc.) for donations to support the cause (the disease) for which the startup is developing a solution (medicine, therapy, medical technology).
A fact unknown by most people
The big pharmaceutical companies and venture capital funds investing in healthcare decide which start-ups can continue the adventure of clinical trials by putting pressure on the small venture capital funds.
The innovation process is therefore not patient-centred but based on the strategic agenda of Big Pharma (an agenda that is not necessarily in line with your mum's cancer or your little sister's incurable genetic disease).
This is what funding for biopharmaceutical startups should look like in a sane world.
But what if ...
You've probably been following the news about the 100% digital influencer created by AI, who earns her creator a lot of money by playing her charms on OnlyFans.
You can guess what I'm thinking?
What if we created one or more AI-generated female influencers who would do all sorts of kinky things on OnlyFans, and with the money, we invested in the capital of health tech start-ups?
Vice for Virtue
Share your thoughts about the idea developed here.
Two examples of revolutionary biotech start-ups looking to raise funds:
CUTISS, which has developed a machine to produce human skin for burn victims. The skin is produced from a 1cm² sample of the patient, so the skin grafts are not rejected by the patient's immune system.
RedC Biotech is developing an infinite source of universal human blood.
Infinite: no more supply problems.
Universal: no more compatibility problems (ABC, Rhesus).